Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian markets trade higher
Tue, 18 Nov 11:30 am

After opening in the green, the Indian Indices are trading above the dotted line during the morning session. Broad based buying is being witnessed in mid and small cap stocks. Metal and capital goods stocks leading the gainers. IT and FMCG stocks are trading in the red.

The BSE-Sensex is trading up 49 points. The NSE-Nifty is trading up 10 points. The BSE Mid Cap index is trading up 0.5% and the BSE Small Cap index is trading up 1%. The rupee is trading at 61.79 to the US dollar.

Majority of Indian pharma stocks are trading firm with Torrent pharma and Glenmark pharma being the leading gainers in the pack. As per financial daily, Sun pharmaceuticals has voluntarily recalling 68,194 bottles of its Venlafaxine Hydrochloride Extended-Release tablets, used to treat major depressive disorder, in the US market. Reportedly, the reason for this recall is failure in dissolution specification. The 37.5 mg tablets in 30-count bottles and 90-count bottles were manufactured at its Halol facility. Further, the said recall was initiated on September 26 and has been classified as 'Class-II recall'. As per the USFDA website, class II recall is defined as "a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote". This is not expected to have much impact on the company's revenues. However, increase in such recalls can hamper the company's profitability.

Most software stocks are trading lower today. Tech Mahindra and HCL Technologies are leading the losers. As per a leading financial daily, India's fifth largest software firm Tech Mahindra, has launched an internal social networking site. This has been done to enable better communication with its employee base. The company will also sell the platform to its existing clients. Enterprise social networking has been a growth area recently for IT firms and Tech Mahindra is looking to cash in on the trend. The platform will also help to increase efficiency by reduced the number of internal e-mails and enable better communication across departments. India's largest IT firm, TCS had earlier developed an internal social network called 'Knome' and has begun marketing it to its clients. The stock of Tech Mahindra was trading down 0.7% at the time of writing.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian markets trade higher". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.